“Widespread adoption of the BCG plus mitomycin regimen would actually help to resolve that BCG shortage," says Professor Dickon Hayne.
Professor Dickon Hayne
Advertisement
Articles by Professor Dickon Hayne
Hayne finds the emergence of antibody drugs conjugates in urothelial cancer to be particularly intriguing.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
Michael Cookson, MD, discusses new strategies for treatment intensification in prostate cancer
5
